Stock Report

Download full stock data and analysis for free Last Updated: 30-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Onyx Biotec Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ONYX

₹42.05

₹0.00 (0.00%)

As on 28-Aug-2026IST

Market cap

info icon

₹76 Cr

Revenue (TTM)

info icon

₹62 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 15.26 11.36 --
EBIT -- -- 12.34 19.22 --
Net Profit -- -- 36.31 13.90 --
EPS -- -- 0.15 -1.29 --
Book Value -- -- 61.61 30.28 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 10.52--11.8312.137.59
Net Margin info 6.42--7.856.754.66
Return on equity info 13.21--12.2516.7110.67
Return on Capital info 11.58--13.6812.858.21
Return on Assets info 5.11--5.995.473.86
Debt to Equity (x) info ----0.221.221.61

Profitability

View Detailed Peer Comparison

ROCE

13.68

Higher than Peers by 1.49

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
13.68
12.85
8.21
15.52
--
Peer Median
12.19
11.06
9.85
8.65
--
ROE

12.25

Higher than Peers by 2.98

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
12.25
16.71
10.67
20.47
--
Peer Median
9.26
7.17
7.54
3.52
--
ROA

5.99

Lower than Peers by 1.66

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
5.99
5.47
3.86
9.10
--
Peer Median
7.65
3.78
3.99
2.87
--
EBIT Margin

11.83

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
11.83
12.13
7.59
9.64
--
Peer Median
--
12.49
13.66
32.74
--
Net Margin

7.85

Higher than Peers by 2.22

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
7.85
6.75
4.66
7.45
--
Peer Median
5.63
2.96
2.70
2.53
--
Cash Profit Margin

12.92

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
12.92
10.24
8.45
10.70
--
Peer Median
--
0.00
0.00
0.00
--

Growth

View Detailed Peer Comparison

Revenue Growth

15.26

--

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
15.26
36.14
-11.99
--
--
Peer Median
--
39.85
38.90
--
--
EBIT Growth

12.34

--

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
12.34
117.62
-30.69
--
--
Peer Median
--
20.42
176.64
--
--
Net Profit Growth

36.31

--

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
36.31
97.04
-44.98
--
--
Peer Median
--
12.85
218.06
--
--
EPS Growth

0.15

--

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
0.15
74.57
-44.98
--
--
Peer Median
--
33.33
200.00
--
--
Book Value Growth

119.96

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
119.96
38.93
11.15
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.22

Lower than Peers by 0.00

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
0.22
1.22
1.61
0.75
--
Peer Median
0.22
0.20
0.19
0.38
--
Short term debt to equity ratio

0.07

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
0.07
0.12
0.40
0.08
--
Peer Median
--
--
--
--
--
Current Ratio

1.91

Lower than Peers by 0.08

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
1.91
1.31
0.72
1.44
--
Peer Median
1.99
2.03
1.95
1.92
--
Quick Ratio

1.29

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
1.29
0.91
0.42
1.17
--
Peer Median
--
1.12
1.24
5.88
--
Interest Coverage

4.21

Higher than Peers by 0.07

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
4.21
3.08
5.43
6.86
--
Peer Median
4.14
2.98
3.48
2.73
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

32.66

--

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
32.66
28.60
12.86
18.76
--
Peer Median
--
29.85
41.06
55.67
--
Asset Turnover

0.75

--

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
0.75
0.81
0.83
1.22
--
Peer Median
--
1.55
3.06
1.38
--
Receivable days

104.89

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
104.89
69.43
62.37
68.49
--
Peer Median
--
--
--
--
--
Inventory Days

74.24

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
74.24
52.40
43.36
24.84
--
Peer Median
--
--
--
--
--
Payable days

142.32

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
142.32
105.74
97.57
59.40
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

36.81

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
36.81
16.09
8.16
33.92
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

21.23

Lower than Peers by 22.97

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
21.23
--
--
--
--
Peer Median
44.20
39.23
34.42
43.43
--
Price / Book Value

1.89

Lower than Peers by 1.07

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
1.89
--
--
--
--
Peer Median
2.96
2.56
2.03
1.76
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
--
--
--
--
--
Peer Median
--
--
--
--
--
EV/EBITDA

9.45

Lower than Peers by 13.71

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
9.45
5.01
7.61
3.08
--
Peer Median
23.15
24.73
22.79
18.08
--
Market Cap

105

Higher than Peers by 51

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Onyx Biotec
105
--
--
--
--
Peer Median
55
58
40
20
--
loading...
loading...
loading...